chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Headache, Injection site pain, Pain in extremity, Pyrexia, Vaccination site erythema
Clinical narrative: "red circle a silver dollar size" on injection site /injection site was still red; tender injection site; headache; sore arm; "feverish" injection site"; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), PYREXIA ("feverish" injection site"), VACCINATION SITE ERYTHEMA ("red circle a silver dollar size" on injection site /injection site was still red), INJECTION SITE PAIN (tender injection site) and HEADACHE (headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and PYREXIA ("feverish" injection site"). On 17-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA ("red circle a silver dollar size" on injection site /injection site was still red), INJECTION SITE PAIN (tender injection site) and HEADACHE (headache). On 09-Mar-2021, PAIN IN EXTREMITY (sore arm) and PYREXIA ("feverish" injection site") had resolved. At the time of the report, VACCINATION SITE ERYTHEMA ("red circle a silver dollar size" on injection site /injection site was still red), INJECTION SITE PAIN (tender injection site) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient reported that the injection site erythema was red circle and a silver dollar size. No concomitant medication was reported No treatment medication was reported
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash pruritic
Clinical narrative: Rash all over his body; still itchy; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash all over his body) and RASH PRURITIC (still itchy) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN (LIPTOR [ATORVASTATIN]) for an unknown indication.    On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, the patient experienced RASH (Rash all over his body) and RASH PRURITIC (still itchy). The patient was treated with PREDNISOLONE (oral) for Itchy rash, at an unspecified dose and frequency. At the time of the report, RASH (Rash all over his body) and RASH PRURITIC (still itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Menstruation irregular
Clinical narrative: Gets her period on the 1° or 2° of the month, but this time she just got her period today, which is very ununsal; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION IRREGULAR (Gets her period on the 1° or 2° of the month, but this time she just got her period today, which is very ununsal) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M209) for COVID-19 vaccination.     No medical history was provided by the reporter. .  Concomitant products included DENOSUMAB (PROLIA) for an unknown indication.    On 27-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced MENSTRUATION IRREGULAR (Gets her period on the 1° or 2° of the month, but this time she just got her period today, which is very ununsal). At the time of the report, MENSTRUATION IRREGULAR (Gets her period on the 1° or 2° of the month, but this time she just got her period today, which is very ununsal) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Neck mass, Pain in extremity
Clinical narrative: No energy since the 2nd dose, Weak since the 2nd dose; Tired since the 2nd dose; Knot on side of neck after 1st dose; Bigger knot on side of neck after 2nd dose; Pain in right leg; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in right leg), ASTHENIA (No energy since the 2nd dose, Weak since the 2nd dose), FATIGUE (Tired since the 2nd dose), NECK MASS (Knot on side of neck after 1st dose) and NECK MASS (Bigger knot on side of neck after 2nd dose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in right leg). On an unknown date, the patient experienced ASTHENIA (No energy since the 2nd dose, Weak since the 2nd dose), FATIGUE (Tired since the 2nd dose), NECK MASS (Knot on side of neck after 1st dose) and NECK MASS (Bigger knot on side of neck after 2nd dose). At the time of the report, PAIN IN EXTREMITY (Pain in right leg), ASTHENIA (No energy since the 2nd dose, Weak since the 2nd dose), FATIGUE (Tired since the 2nd dose), NECK MASS (Knot on side of neck after 1st dose) and NECK MASS (Bigger knot on side of neck after 2nd dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant Medication was reported by reporter. No Treatment Medication was not reported by reporter.   This case was linked to MOD-2021-201718 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 06-Apr-2021: Follow-up information received on 06-04-2021 contains non-significant information. On 02-Jun-2021: Reporter's address, New event were added.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: injection site was very itchy and red; injection site was very itchy and red; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (injection site was very itchy and red) and VACCINATION SITE PRURITUS (injection site was very itchy and red) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025A21A) for COVID-19 vaccination.     Concomitant products included VITAMINS NOS for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site was very itchy and red) and VACCINATION SITE PRURITUS (injection site was very itchy and red). The patient was treated with CALAMINE, GLYCEROL, ZINC OXIDE (CALAMINE LOTION) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE ERYTHEMA (injection site was very itchy and red) and VACCINATION SITE PRURITUS (injection site was very itchy and red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Hot to the touch; Red patch the size of her hand under the injection site; Swollen; Chills; Slight headache; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE WARMTH (Hot to the touch), INJECTION SITE ERYTHEMA (Red patch the size of her hand under the injection site), INJECTION SITE SWELLING (Swollen), CHILLS (Chills) and HEADACHE (Slight headache) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029a21a) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high, Cancer and Thyroid disorder.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced INJECTION SITE WARMTH (Hot to the touch), INJECTION SITE ERYTHEMA (Red patch the size of her hand under the injection site), INJECTION SITE SWELLING (Swollen), CHILLS (Chills) and HEADACHE (Slight headache). At the time of the report, INJECTION SITE WARMTH (Hot to the touch), INJECTION SITE ERYTHEMA (Red patch the size of her hand under the injection site), INJECTION SITE SWELLING (Swollen), CHILLS (Chills) and HEADACHE (Slight headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient's concomitant medications included unspecified medicines for blood pressure, thyroid and cancer.   No treatment information was provided by the reporter.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles on the Right side of Face, Right side of Neck, Right Ear and Right side of her back; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 17-Mar-2021 and was forwarded to Moderna on 17-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (Shingles on the Right side of Face, Right side of Neck, Right Ear and Right side of her back) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 on 09-Nov-2020.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced HERPES ZOSTER (Shingles on the Right side of Face, Right side of Neck, Right Ear and Right side of her back). At the time of the report, HERPES ZOSTER (Shingles on the Right side of Face, Right side of Neck, Right Ear and Right side of her back) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  Treatment information was not provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Dysuria, Headache
Clinical narrative: Headaches; Burning Urination; Feeling lightheaded; This spontaneous case was reported by a consumer and describes the occurrence of DYSURIA (Burning Urination), DIZZINESS (Feeling lightheaded) and HEADACHE (Headaches) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced DYSURIA (Burning Urination) and DIZZINESS (Feeling lightheaded). On 20-Mar-2021, the patient experienced HEADACHE (Headaches). At the time of the report, DYSURIA (Burning Urination), DIZZINESS (Feeling lightheaded) and HEADACHE (Headaches) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No Concomitant medications was provided.  No treatment medication was provided.  Patient got her second shot on 18-Apr-2021.   This case was linked to MOD-2021-267205 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: New adverse event was added. First dose information was updated. Action taken updated.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pollakiuria
Clinical narrative: going to the bathroom uncontrollably a lot; This spontaneous case was reported by a consumer and describes the occurrence of POLLAKIURIA (going to the bathroom uncontrollably a lot) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040A21A and 030MZ0A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 16-Mar-2021, the patient experienced POLLAKIURIA (going to the bathroom uncontrollably a lot). At the time of the report, POLLAKIURIA (going to the bathroom uncontrollably a lot) outcome was unknown.       Concomitant product use were not provided by the reporter.   ?No treatment information was provided. ?Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: No new information added.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Rash macular, Vaccination site erythema
Clinical narrative: big red spot on arm; Spot not going away; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (big red spot on arm) and RASH MACULAR (Spot not going away) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031A21A and 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Cholesterol.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In March 2021, the patient experienced VACCINATION SITE ERYTHEMA (big red spot on arm) and RASH MACULAR (Spot not going away). At the time of the report, VACCINATION SITE ERYTHEMA (big red spot on arm) and RASH MACULAR (Spot not going away) had not resolved.            Concomitant medications include cholesterol medication and Blood pressure medication.  Treatment medications were not provided.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Pain, Pain in extremity
Clinical narrative: A little sore; Stiff; Pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (A little sore), MUSCULOSKELETAL STIFFNESS (Stiff) and PAIN (Pain) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Open heart surgery and Back surgery. Concurrent medical conditions included Cancer and Diabetes.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (A little sore), MUSCULOSKELETAL STIFFNESS (Stiff) and PAIN (Pain). At the time of the report, PAIN IN EXTREMITY (A little sore), MUSCULOSKELETAL STIFFNESS (Stiff) and PAIN (Pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Products known to have been used by the patient, within two weeks prior to the event, included unspecified medications.  Treatment information was not provided.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site swelling, Vaccination site warmth
Clinical narrative: Painful on injection site; Hot on injection site/Arm was warm; Itching on injection site; Swollen injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Painful on injection site), VACCINATION SITE WARMTH (Hot on injection site/Arm was warm), VACCINATION SITE PRURITUS (Itching on injection site) and VACCINATION SITE SWELLING (Swollen injection site) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 026A21A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy NOS. Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PAIN (Painful on injection site), VACCINATION SITE WARMTH (Hot on injection site/Arm was warm), VACCINATION SITE PRURITUS (Itching on injection site) and VACCINATION SITE SWELLING (Swollen injection site). At the time of the report, VACCINATION SITE PAIN (Painful on injection site), VACCINATION SITE WARMTH (Hot on injection site/Arm was warm), VACCINATION SITE PRURITUS (Itching on injection site) and VACCINATION SITE SWELLING (Swollen injection site) outcome was unknown.            Concomitant medications included medication for allergy and blood pressure (unspecified).  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events was not applicable.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: Itching; Rash; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Itching) and RASH (Rash) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Mar-2021, the patient experienced PRURITUS (Itching) and RASH (Rash). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Itching and Rash, at an unspecified dose and frequency; HYDROXYZINE for Itching and Rash, at an unspecified dose and frequency and TRIAMCINOLONE (topical) for Itching and Rash, at an unspecified dose and frequency. At the time of the report, PRURITUS (Itching) and RASH (Rash) outcome was unknown.            No relevant concomitant medications were reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Livedo reticularis
Clinical narrative: Red, purplish discoloration behind both knees; This spontaneous case was reported by a consumer and describes the occurrence of LIVEDO RETICULARIS (Red, purplish discoloration behind both knees) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, the patient experienced LIVEDO RETICULARIS (Red, purplish discoloration behind both knees). At the time of the report, LIVEDO RETICULARIS (Red, purplish discoloration behind both knees) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  The discoloration behind the knees was fading away over time.  Treatment information was not provided.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: Vertigo; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo) and DIZZINESS (Dizziness) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     Concurrent medical conditions included Vertigo (had an incident of vertigo last year).    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced VERTIGO (Vertigo) and DIZZINESS (Dizziness). At the time of the report, VERTIGO (Vertigo) and DIZZINESS (Dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were provided. No treatment information was provided. Patient  had the symptoms while moving from  laying down to an upright position or simply turning head while in bed.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Gait inability, Headache, Illness
Clinical narrative: ill; temperature was 102.4 /fever; legs didn't feel like they were strong enough to stand up; chills /periods of violent chills; weakness; large fever blisters on my lip; trembling violently for half an hour to forty minutes; sore neck; brief headache; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (ill), PYREXIA (temperature was 102.4 /fever), GAIT INABILITY (legs didn't feel like they were strong enough to stand up), CHILLS (chills /periods of violent chills) and ASTHENIA (weakness) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced ILLNESS (ill), PYREXIA (temperature was 102.4 /fever), GAIT INABILITY (legs didn't feel like they were strong enough to stand up), CHILLS (chills /periods of violent chills), ASTHENIA (weakness), ORAL HERPES (large fever blisters on my lip), TREMOR (trembling violently for half an hour to forty minutes), NECK PAIN (sore neck) and HEADACHE (brief headache). At the time of the report, ILLNESS (ill), PYREXIA (temperature was 102.4 /fever), GAIT INABILITY (legs didn't feel like they were strong enough to stand up), CHILLS (chills /periods of violent chills), ASTHENIA (weakness), ORAL HERPES (large fever blisters on my lip), TREMOR (trembling violently for half an hour to forty minutes), NECK PAIN (sore neck) and HEADACHE (brief headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Mar-2021, SARS-CoV-2 test negative: negative (Negative) negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 78.0
Sex: M
Vaccine: COVID19
Symptoms: Neck pain, Oral herpes, Pyrexia, SARS-CoV-2 test negative, Tremor
Clinical narrative: ill; temperature was 102.4 /fever; legs didn't feel like they were strong enough to stand up; chills /periods of violent chills; weakness; large fever blisters on my lip; trembling violently for half an hour to forty minutes; sore neck; brief headache; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (ill), PYREXIA (temperature was 102.4 /fever), GAIT INABILITY (legs didn't feel like they were strong enough to stand up), CHILLS (chills /periods of violent chills) and ASTHENIA (weakness) in a 79-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced ILLNESS (ill), PYREXIA (temperature was 102.4 /fever), GAIT INABILITY (legs didn't feel like they were strong enough to stand up), CHILLS (chills /periods of violent chills), ASTHENIA (weakness), ORAL HERPES (large fever blisters on my lip), TREMOR (trembling violently for half an hour to forty minutes), NECK PAIN (sore neck) and HEADACHE (brief headache). At the time of the report, ILLNESS (ill), PYREXIA (temperature was 102.4 /fever), GAIT INABILITY (legs didn't feel like they were strong enough to stand up), CHILLS (chills /periods of violent chills), ASTHENIA (weakness), ORAL HERPES (large fever blisters on my lip), TREMOR (trembling violently for half an hour to forty minutes), NECK PAIN (sore neck) and HEADACHE (brief headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Mar-2021, SARS-CoV-2 test negative: negative (Negative) negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling cold, Migraine, Myalgia, Pain in extremity, Vomiting
Clinical narrative: migraine; moments of being cold than hot; she was hurting all over.; vomiting up flehm; Her arm started to hurt; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Her arm started to hurt), MIGRAINE (migraine), FEELING COLD (moments of being cold than hot), MYALGIA (she was hurting all over.) and VOMITING (vomiting up flehm) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included Sinusitis. Concomitant products included ELETRIPTAN for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (Her arm started to hurt), FEELING COLD (moments of being cold than hot), MYALGIA (she was hurting all over.) and VOMITING (vomiting up flehm). On 18-Mar-2021, the patient experienced MIGRAINE (migraine). At the time of the report, PAIN IN EXTREMITY (Her arm started to hurt), MIGRAINE (migraine), FEELING COLD (moments of being cold than hot), MYALGIA (she was hurting all over.) and VOMITING (vomiting up flehm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Heart rate, Heart rate increased, Palpitations, Product dose omission issue
Clinical narrative: missed his second dose; Chest Pain; Increased Heart rate; Palpitation; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of CHEST PAIN (Chest Pain), HEART RATE INCREASED (Increased Heart rate), PALPITATIONS (Palpitation) and PRODUCT DOSE OMISSION ISSUE (missed his second dose) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Heart disease, unspecified.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2021, the patient experienced CHEST PAIN (Chest Pain), HEART RATE INCREASED (Increased Heart rate) and PALPITATIONS (Palpitation). On 15-Feb-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (missed his second dose). On 15-Feb-2021, PRODUCT DOSE OMISSION ISSUE (missed his second dose) had resolved. At the time of the report, CHEST PAIN (Chest Pain), HEART RATE INCREASED (Increased Heart rate) and PALPITATIONS (Palpitation) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Jan-2021, Heart rate: increased (High) increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.; Sender's Comments: Very limited information regarding this events has been provided at this time. Further information has been requested. Company assessed the events to be unlikely related to company product.
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Blood test, Chest X-ray, Electrocardiogram, Headache
Clinical narrative: "not feeling well"; her rapid heart rate was from anxiety; "uncomfortable headache"; "rapid heartbeat" /"rapid heartbeat on and off" /"continued rapid heart beat that lasted two weeks"; "not being able to sleep with a caffeine feeling"; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS ("rapid heartbeat" /"rapid heartbeat on and off" /"continued rapid heart beat that lasted two weeks"), INSOMNIA ("not being able to sleep with a caffeine feeling"), MALAISE ("not feeling well"), ANXIETY (her rapid heart rate was from anxiety) and HEADACHE ("uncomfortable headache") in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical information history reported.  Concomitant products included MULTIVITAMINS [VITAMINS NOS] and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PALPITATIONS ("rapid heartbeat" /"rapid heartbeat on and off" /"continued rapid heart beat that lasted two weeks") and INSOMNIA ("not being able to sleep with a caffeine feeling"). On 28-Feb-2021, the patient experienced HEADACHE ("uncomfortable headache"). On 08-Mar-2021, the patient experienced ANXIETY (her rapid heart rate was from anxiety). On 09-Mar-2021, the patient experienced MALAISE ("not feeling well"). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. At the time of the report, PALPITATIONS ("rapid heartbeat" /"rapid heartbeat on and off" /"continued rapid heart beat that lasted two weeks"), INSOMNIA ("not being able to sleep with a caffeine feeling"), MALAISE ("not feeling well"), ANXIETY (her rapid heart rate was from anxiety) and HEADACHE ("uncomfortable headache") had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Mar-2021, Blood test: normal (normal) normal. On 09-Mar-2021, Chest X-ray: normal (normal) normal. On 09-Mar-2021, Electrocardiogram: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient spent six hours in the emergency department and she has been asymptomatic ever since after being discharged.
Sex: F
Vaccine: COVID19
Symptoms: Insomnia, Malaise, Palpitations
Clinical narrative: "not feeling well"; her rapid heart rate was from anxiety; "uncomfortable headache"; "rapid heartbeat" /"rapid heartbeat on and off" /"continued rapid heart beat that lasted two weeks"; "not being able to sleep with a caffeine feeling"; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS ("rapid heartbeat" /"rapid heartbeat on and off" /"continued rapid heart beat that lasted two weeks"), INSOMNIA ("not being able to sleep with a caffeine feeling"), MALAISE ("not feeling well"), ANXIETY (her rapid heart rate was from anxiety) and HEADACHE ("uncomfortable headache") in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical information history reported.  Concomitant products included MULTIVITAMINS [VITAMINS NOS] and VITAMIN C [ASCORBIC ACID] for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PALPITATIONS ("rapid heartbeat" /"rapid heartbeat on and off" /"continued rapid heart beat that lasted two weeks") and INSOMNIA ("not being able to sleep with a caffeine feeling"). On 28-Feb-2021, the patient experienced HEADACHE ("uncomfortable headache"). On 08-Mar-2021, the patient experienced ANXIETY (her rapid heart rate was from anxiety). On 09-Mar-2021, the patient experienced MALAISE ("not feeling well"). The patient was treated with ASPIRIN [ACETYLSALICYLIC ACID] at an unspecified dose and frequency. At the time of the report, PALPITATIONS ("rapid heartbeat" /"rapid heartbeat on and off" /"continued rapid heart beat that lasted two weeks"), INSOMNIA ("not being able to sleep with a caffeine feeling"), MALAISE ("not feeling well"), ANXIETY (her rapid heart rate was from anxiety) and HEADACHE ("uncomfortable headache") had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Mar-2021, Blood test: normal (normal) normal. On 09-Mar-2021, Chest X-ray: normal (normal) normal. On 09-Mar-2021, Electrocardiogram: normal (normal) normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient spent six hours in the emergency department and she has been asymptomatic ever since after being discharged.
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site erythema, Vaccination site pain
Clinical narrative: Redness over the injection site looks like a Bullseye/ red area growing; fever; Really hurting; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness over the injection site looks like a Bullseye/ red area growing), PYREXIA (fever) and VACCINATION SITE PAIN (Really hurting) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced VACCINATION SITE ERYTHEMA (Redness over the injection site looks like a Bullseye/ red area growing), PYREXIA (fever) and VACCINATION SITE PAIN (Really hurting). At the time of the report, VACCINATION SITE ERYTHEMA (Redness over the injection site looks like a Bullseye/ red area growing), PYREXIA (fever) and VACCINATION SITE PAIN (Really hurting) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  No treatment medication was reported.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Pain
Clinical narrative: little soreness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (little soreness) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Heart disorder and Blood pressure high. Concomitant products included ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (little soreness). At the time of the report, PAIN (little soreness) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Patient's concomitant medication also included unspecified blood thinner twice daily for irregular heart beat and for blood pressure.  No treatment information was provided.   This case was linked to MOD-2021-049445 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: rash on neck and back; This spontaneous case was reported by a pharmacist and describes the occurrence of RASH (rash on neck and back) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced RASH (rash on neck and back). At the time of the report, RASH (rash on neck and back) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported.  Treatment medications was not provided by the reporter   Reporter did not allow further contact
Age: 53.0
Sex: U
Vaccine: COVID19
Symptoms: Poor quality product administered, Product temperature excursion issue
Clinical narrative: received vaccine after temperature excursion; received vaccine after temperature excursion; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (received vaccine after temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (received vaccine after temperature excursion) in a 53-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (received vaccine after temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (received vaccine after temperature excursion). In March 2021, PRODUCT TEMPERATURE EXCURSION ISSUE (received vaccine after temperature excursion) and POOR QUALITY PRODUCT ADMINISTERED (received vaccine after temperature excursion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.  Treatment medications was not provided by the reporter
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Breast induration, Breast pain, Fatigue, Limb discomfort
Clinical narrative: Sore arm; breast hardness and hurting; breast hardness and hurting; swelling on hands and feet; could not move the arm , could not put clothes neither use ring; joint hurting; shoulder cracking; was in bed all day; Fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Sore arm), BREAST PAIN (breast hardness and hurting), BREAST INDURATION (breast hardness and hurting), PERIPHERAL SWELLING (swelling on hands and feet) and LIMB DISCOMFORT (could not move the arm , could not put clothes neither use ring) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Sore arm), BREAST PAIN (breast hardness and hurting), BREAST INDURATION (breast hardness and hurting), PERIPHERAL SWELLING (swelling on hands and feet), LIMB DISCOMFORT (could not move the arm , could not put clothes neither use ring), ARTHRALGIA (joint hurting), ARTHRALGIA (shoulder cracking), FATIGUE (was in bed all day ) and PYREXIA (Fever). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Sore arm), BREAST PAIN (breast hardness and hurting), BREAST INDURATION (breast hardness and hurting), PERIPHERAL SWELLING (swelling on hands and feet), ARTHRALGIA (joint hurting), ARTHRALGIA (shoulder cracking), FATIGUE (was in bed all day ) and PYREXIA (Fever) outcome was unknown and LIMB DISCOMFORT (could not move the arm , could not put clothes neither use ring) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Event outcome updated.  Patient denied to further follow-up.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling, Pyrexia, Vaccination site movement impairment
Clinical narrative: Sore arm; breast hardness and hurting; breast hardness and hurting; swelling on hands and feet; could not move the arm , could not put clothes neither use ring; joint hurting; shoulder cracking; was in bed all day; Fever; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE MOVEMENT IMPAIRMENT (Sore arm), BREAST PAIN (breast hardness and hurting), BREAST INDURATION (breast hardness and hurting), PERIPHERAL SWELLING (swelling on hands and feet) and LIMB DISCOMFORT (could not move the arm , could not put clothes neither use ring) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced VACCINATION SITE MOVEMENT IMPAIRMENT (Sore arm), BREAST PAIN (breast hardness and hurting), BREAST INDURATION (breast hardness and hurting), PERIPHERAL SWELLING (swelling on hands and feet), LIMB DISCOMFORT (could not move the arm , could not put clothes neither use ring), ARTHRALGIA (joint hurting), ARTHRALGIA (shoulder cracking), FATIGUE (was in bed all day ) and PYREXIA (Fever). At the time of the report, VACCINATION SITE MOVEMENT IMPAIRMENT (Sore arm), BREAST PAIN (breast hardness and hurting), BREAST INDURATION (breast hardness and hurting), PERIPHERAL SWELLING (swelling on hands and feet), ARTHRALGIA (joint hurting), ARTHRALGIA (shoulder cracking), FATIGUE (was in bed all day ) and PYREXIA (Fever) outcome was unknown and LIMB DISCOMFORT (could not move the arm , could not put clothes neither use ring) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided by the reporter.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Event outcome updated.  Patient denied to further follow-up.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Fatigue, Feeling abnormal, Pain in extremity
Clinical narrative: diarrhea; arm very painful; felt herself miserable; felt tired at night; chills; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), PAIN IN EXTREMITY (arm very painful), FEELING ABNORMAL (felt herself miserable), FATIGUE (felt tired at night) and CHILLS (chills) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B) for COVID-19 vaccination.     No medical history reported.  Concomitant products included LAMOTRIGINE (LAMICTAL), PRAZOSIN, DULOXETINE HYDROCHLORIDE (CYMBALTA), DOXEPIN and HYDROXYZINE EMBONATE (VISTARIL [HYDROXYZINE EMBONATE]) for an unknown indication.    On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced DIARRHOEA (diarrhea), PAIN IN EXTREMITY (arm very painful), FEELING ABNORMAL (felt herself miserable), FATIGUE (felt tired at night) and CHILLS (chills). At the time of the report, DIARRHOEA (diarrhea), PAIN IN EXTREMITY (arm very painful), FEELING ABNORMAL (felt herself miserable), FATIGUE (felt tired at night) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient did not take any treatment for the symptoms.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: pregnant consumer; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnant consumer) in a 34-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     The patient's past medical history included Alcohol use (prior use). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 30-Sep-2021. On 18-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnant consumer). On 18-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (pregnant consumer) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jan-2021, Pregnancy test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided  No concomitant information was provided   Previous pregnancy had outcome of live full-term birth with gestational diabetes as a complication on 28-Dec-2019.
Sex: F
Vaccine: COVID19
Symptoms: Tremor
Clinical narrative: Tremors; This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Tremors) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No medical information history was reported.  Concomitant products included GABAPENTIN, MINOXIDIL, EZETIMIBE and ATORVASTATIN for an unknown indication.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced TREMOR (Tremors). At the time of the report, TREMOR (Tremors) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment was taken by the patient for the event.
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: red itchy rash at the injection site; red itchy rash at the injection site, 2.5 inches in diameter now, has gotten larger; This spontaneous case was reported by an other caregiver and describes the occurrence of VACCINATION SITE PRURITUS (red itchy rash at the injection site) and VACCINATION SITE RASH (red itchy rash at the injection site, 2.5 inches in diameter now, has gotten larger) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (red itchy rash at the injection site) and VACCINATION SITE RASH (red itchy rash at the injection site, 2.5 inches in diameter now, has gotten larger). At the time of the report, VACCINATION SITE PRURITUS (red itchy rash at the injection site) and VACCINATION SITE RASH (red itchy rash at the injection site, 2.5 inches in diameter now, has gotten larger) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication was reported.  No treatment information was provided.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Nausea
Clinical narrative: weak; tired; nauseous; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (weak), FATIGUE (tired) and NAUSEA (nauseous) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced ASTHENIA (weak), FATIGUE (tired) and NAUSEA (nauseous). The patient was treated with DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, EPHEDRINE SULFATE, ETHANOL, PARACETAMOL (NYQUIL) on 16-Mar-2021 for Adverse reaction, at a dose of 1 dosage form. At the time of the report, ASTHENIA (weak), FATIGUE (tired) and NAUSEA (nauseous) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported.    Reporter did not allow further contact